Aminologics Co.,Ltd.

KOSDAQ:A074430 Stock Report

Market Cap: ₩82.0b

AminologicsLtd Past Earnings Performance

Past criteria checks 2/6

AminologicsLtd's earnings have been declining at an average annual rate of -16.4%, while the Chemicals industry saw earnings growing at 8.5% annually. Revenues have been growing at an average rate of 4.7% per year. AminologicsLtd's return on equity is 3.4%, and it has net margins of 8.9%.

Key information

-16.4%

Earnings growth rate

-16.4%

EPS growth rate

Chemicals Industry Growth13.9%
Revenue growth rate4.7%
Return on equity3.4%
Net Margin8.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

There May Be Underlying Issues With The Quality Of AminologicsLtd's (KOSDAQ:074430) Earnings

Nov 15
There May Be Underlying Issues With The Quality Of AminologicsLtd's (KOSDAQ:074430) Earnings

AminologicsLtd's (KOSDAQ:074430) Shareholders May Want To Dig Deeper Than Statutory Profit

Mar 27
AminologicsLtd's (KOSDAQ:074430) Shareholders May Want To Dig Deeper Than Statutory Profit

Recent updates

There May Be Underlying Issues With The Quality Of AminologicsLtd's (KOSDAQ:074430) Earnings

Nov 15
There May Be Underlying Issues With The Quality Of AminologicsLtd's (KOSDAQ:074430) Earnings

AminologicsLtd (KOSDAQ:074430) May Have Issues Allocating Its Capital

Aug 13
AminologicsLtd (KOSDAQ:074430) May Have Issues Allocating Its Capital

AminologicsLtd's (KOSDAQ:074430) Shareholders May Want To Dig Deeper Than Statutory Profit

Mar 27
AminologicsLtd's (KOSDAQ:074430) Shareholders May Want To Dig Deeper Than Statutory Profit

Some Investors May Be Worried About AminologicsLtd's (KOSDAQ:074430) Returns On Capital

Mar 01
Some Investors May Be Worried About AminologicsLtd's (KOSDAQ:074430) Returns On Capital

Returns At AminologicsLtd (KOSDAQ:074430) Are On The Way Up

May 05
Returns At AminologicsLtd (KOSDAQ:074430) Are On The Way Up

Should Weakness in Aminologics Co.,Ltd.'s (KOSDAQ:074430) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Mar 19
Should Weakness in Aminologics Co.,Ltd.'s (KOSDAQ:074430) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

If You Had Bought AminologicsLtd (KOSDAQ:074430) Stock Five Years Ago, You Could Pocket A 137% Gain Today

Feb 04
If You Had Bought AminologicsLtd (KOSDAQ:074430) Stock Five Years Ago, You Could Pocket A 137% Gain Today

Revenue & Expenses Breakdown

How AminologicsLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A074430 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2420,8861,8574,4951,246
30 Jun 2422,6622,8374,4791,225
31 Mar 2421,7262,5754,4931,236
31 Dec 2320,8872,4364,5271,307
30 Sep 2318,798-13,2565,396165
30 Jun 2322,265-10,1225,574199
31 Mar 2323,275-9,3575,530210
31 Dec 2227,337-7,2825,305216
30 Sep 2227,8565,7465,383208
30 Jun 2224,6334,1284,937342
31 Mar 2226,6027,7174,629382
31 Dec 2122,8495,3604,405474
30 Sep 2120,5967,3213,976563
30 Jun 2121,3697,0733,918460
31 Mar 2117,9963,4423,778405
31 Dec 2017,6512,1403,805340
30 Sep 2018,312-1,4683,714284
30 Jun 2017,219-2,1803,761264
31 Mar 2017,570-2,7893,867297
31 Dec 1918,980-1,2013,578226
30 Sep 1918,9645,909-124202
30 Jun 1919,2266,864-343202
31 Mar 1920,0618,182-488137
31 Dec 1818,4507,996-581161
30 Sep 1817,7582,9772,389269
30 Jun 1817,3352,3072,164268
31 Mar 1816,6388832,062251
31 Dec 1716,8355421,897225
30 Sep 1716,463-3,5692,114195
30 Jun 1716,845-3,5202,058171
31 Mar 1716,541-3,6022,179167
31 Dec 1616,366-3,7422,335153
30 Sep 1618,3262,8912,14554
30 Jun 1617,1612,9902,41758
31 Mar 1614,050-1,4472,31463
31 Dec 1510,997-2,8252,35977
30 Sep 156,404-10,0692,946114
30 Jun 154,033-11,3502,949144
31 Mar 153,941-8,2782,962145
31 Dec 143,541-8,1003,159168
30 Sep 143,147-10,0132,244144
30 Jun 142,732-11,2812,419102
31 Mar 142,192-12,4883,54591
31 Dec 133,276-13,3894,61043

Quality Earnings: A074430 has a large one-off gain of ₩978.7M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: A074430 became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A074430 has become profitable over the past 5 years, growing earnings by -16.4% per year.

Accelerating Growth: A074430 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: A074430 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (21%).

Return on Equity

High ROE: A074430's Return on Equity (3.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 16:58
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aminologics Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution